Ferriprox Approval History
- FDA approved: Yes (First approved October 14th, 2011)
- Brand name: Ferriprox
- Generic name: deferiprone
- Company: ApoPharma Inc.
- Treatment for: Hemosiderosis
Ferriprox (deferiprone) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
FDA Approval History for Ferriprox
|Oct 14, 2011||FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body|
|Sep 14, 2011||ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox (deferiprone) Approval|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.